President Trump has claimed his drug pricing initiatives will secure Republican victories in the midterm elections, but voters in Florida’s Seventh Congressional District report no financial relief. James Evans, 37, a real estate agent without prescription coverage, stated he remains one bad diagnosis away from bankruptcy, noting that while some drug prices may drop, overall costs continue to rise. The district, which Trump won by 12 points in 2024, has one of the highest rates of Affordable Care Act (A.
C. A.) plan enrollment in the country. Enrollment fell by 11 percent—or 13,000 people—this year following the expiration of pandemic-era subsidies, according to KFF.
Florida is also among 10 states that have not expanded Medicaid, leaving many lower-income adults uninsured. Emily Bellairs-Romero, 57, spent $3,400 on Crohn’s disease medication this year, up from $60 previously, due to insurance changes. With her husband planning to retire in two years, she fears affording insurance until Medicare eligibility at 65.
Lorraine Little, 64, pays $208 monthly for her A. C. A. plan—about one-fifth of her Social Security income—and recently received notice of an increase to $345 in January.
Despite Trump’s efforts, including the Trump Rx website and deals with drug companies, voters say they still feel overcharged. White House spokesperson Allison Schuster claimed "countless Americans" have seen savings, while local Republican organizer Linda Trocine praised efforts to align U.S. drug prices with other wealthy nations. However, residents continue to cite health care costs as their top concern ahead of the election.
Source: New York Times Business · Summarized by HeadlinesBriefing